Reduced hsa-miR-124-3p levels are associated with the poor survival of patients with hepatocellular carcinoma

@article{Long2018ReducedHL,
  title={Reduced hsa-miR-124-3p levels are associated with the poor survival of patients with hepatocellular carcinoma},
  author={Huideng Long and Yushui Ma and Huiqiong Yang and Shao-Bo Xue and Jibin Liu and Fei Yu and Zhongwei Lv and Jiyong Li and Ru-ting Xie and Zhengyan Chang and Gaixia Lu and Wenting Xie and Da Fu and Lijuan Pang},
  journal={Molecular Biology Reports},
  year={2018},
  volume={45},
  pages={2615-2623}
}
Hsa-MicroRNA-124a-3p (hsa-miR-124-3p) is involved in tumor progression in certain malignant tumors. However, its function and clinical implication in hepatocellular carcinoma (HCC) have not yet been illustrated. In this study, we explored the expression and prognostic value of hsa-miR-124-3p in patients with HCC. Hsa-miR-124-3p expression in HCC was analyzed in silico, which was subsequently confirmed by quantitative PCR in 155 HCC biopsy samples. Overall survival (OS) and disease-free survival… 
miR-124-3p Suppresses the Invasiveness and Metastasis of Hepatocarcinoma Cells via Targeting CRKL
TLDR
Mechanistic investigations showed that CRKL downregulation suppresses the ERK pathway and EMT process, and concomitant decrease in invasion and metastasis of HCC cells, illustrating that miR-124-3p acts as an important tumor-suppressive miRNA to suppress HCC carcinogenesis through targetingCRKL.
miR-124-3p combined with miR-506-3p delay hepatic carcinogenesis via modulating sirtuin 1
  • H. Xiang, Ming Luo, Linquan Wu
  • Biology
    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
  • 2021
TLDR
It was observed thatmiR-124-3p and miR-506-3P could cooperatively retard liver cancer cell growth via co-inhibiting SIRT1 protein expression.
MicroRNA-29a and MicroRNA-124 as novel biomarkers for hepatocellular Carcinoma.
MiR-124-3p Suppresses Prostatic Carcinoma by Targeting PTGS2 Through the AKT/NF-κB Pathway
TLDR
Findings provided information that miR-124-3p exerted anti-tumor effects in prostatic carcinoma by targeting PTGS2 to inactivate the AKT/NF-κB pathway.
Diagnostic and prognostic value of microRNA-193b in patients with glioma and its effect on tumor progression
TLDR
The findings from the present study indicate that the overexpression of miR-193b serves as a useful biomarker for the diagnosis and prediction of prognosis in glioma.
MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1
TLDR
The data reveal that miR-124-3p.1 represents a predictive indicator of early recurrence and sorafenib sensitivity in HCC and enhances the curative efficacy of sorafENib through dual effects on FOXO3a, which is implicated as a potential target for the diagnosis and treatment of HCC.
Upregulation of miR-124-3p by Liver X Receptor Inhibits the Growth of Hepatocellular Carcinoma Cells Via Suppressing Cyclin D1 and CDK6
TLDR
It is demonstrated that the expression of mir-124-3p was positively correlated with that of LXR in HCC, and the cell growth of HCC was significantly inhibited by LXR agonists, and LXR-miR-124 -3p-cyclin D1/CDK6 pathway may be a novel potential therapeutic target for HCC treatment.
The potential role of miR-124-3p in tumorigenesis and other related diseases.
TLDR
This review mainly focuses on the most recent years of literature on the functions of miR-124-3p in related major cancers, as well as its downstream target genes.
Role of MicroRNA-124 as a Prognostic Factor in Multiple Neoplasms: A Meta-Analysis
TLDR
The results suggest that miR-124 plays an antioncogenic role in various tumors, such as lung cancer and colorectal cancer, and may be a promising biomarker and novel therapeutic target.
...
...

References

SHOWING 1-10 OF 42 REFERENCES
Upregulation of microRNA-32 is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma
TLDR
The present study is the first study to indicate the association between increased miR-32 expression with HCC progression and poor prognosis in patients, and suggests that mi R-32 may have potential prognostic value and may be used as a tumor biomarker for the diagnosis of patients with H CC.
Identification of miR-124a as a novel diagnostic and prognostic biomarker in non-small cell lung cancer for chemotherapy
TLDR
It is demonstrated thatmiR-124a was downregulated in NSCLC, and miR- 124a was a potential prognostic tumor biomarker response to chemotherapy, and high expression of miR -124awith chemotherapy may increase OS.
MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma.
TLDR
Overall and progression-free survival time was decreased in patients expressing low miR-33a with multiple tumor foci, suggesting that the low expression of miR -33a may be a potential risk factor for HCC.
High expression of miR-105-1 positively correlates with clinical prognosis of hepatocellular carcinoma by targeting oncogene NCOA1
TLDR
The results provide the first evidence that NCOA1 is a direct target of miR-105-1 suggesting that N COA1 andmiR- 105-1 may have potential prognostic value and may be useful as tumor biomarkers for the diagnosis of HCC patients.
Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy
TLDR
It is implied that miR-33a expression levels may have an essential role in NSCLC progression, and could act as a specific and sensitive biomarker forNSCLC patients who have undergone adjuvant chemotherapy.
High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1
TLDR
ITGB1 and miR-493-5p may have potential prognostic value and may be useful as tumor biomarkers for the diagnosis of NSCLC patients and provide the first evidence that ITGB1 is a direct target of miR -493- 5p.
MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.
TLDR
It is demonstrated that miR-124a could function as a potent tumor suppressor by regulation of multiple targets, and was epigenetically silenced in the development of uveal melanoma.
Up-regulated microRNA-299 corrected with poor prognosis of glioblastoma multiforme patients by targeting ELL2
TLDR
Increased ELL2 expression and down-regulation of miR-299 are associated with GBM progression and poor prognosis in patients, suggesting that ELL1 and miR -299 might have potential prognostic value and be used as tumor biomarkers for the diagnosis of patients with G BM.
MicroRNA-340 inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting JAK1.
...
...